Comparison of two strategies of peripheral blood progenitor cells induction with lenalidomide/dexamethasone in newly diagnosed multiple myeloma patients, followed by transplantation and lenalidomide maintenance treatment

Francisco Javier Capote Huelva,Eduardo Rios-Herranz,Miguel Ángel Álvarez Rivas,José Joaquin Ruiz Arredondo,Antonio Alcalá Muñoz,Alicia Bailén-García,José Luis Guzman-Zamudio,Gemma Ramirez,Antonio Fernández Jurado

Comparison of two strategies of peripheral blood progenitor cells induction with lenalidomide/dexamethasone in newly diagnosed multiple myeloma patients, followed by transplantation and lenalidomide maintenance treatment

2018

Francisco Javier Capote Huelva
Eduardo Rios-Herranz
Miguel Ángel Álvarez Rivas
José Joaquin Ruiz Arredondo
Antonio Alcalá Muñoz
Alicia Bailén-García
José Luis Guzman-Zamudio
Gemma Ramirez
Antonio Fernández Jurado

Abstract Background: The most common therapy in young multiple myeloma patients include induction, mobilization, collection and graft of peripheral blood stem cells. The present phase 2, multi-center, randomized study

Keywords:

Progenitor cell
Dexamethasone
Randomized controlled trial
Lenalidomide
Oncology
Peripheral
Transplantation
Mobilization
Medicine
Internal medicine
Multiple myeloma
Peripheral Blood Stem Cells

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations